A Comparative Study Of Oxytocin versus Carbetocin In Decreasing Intraoperative Bleeding During Cesarean Sectio
Phase 3
- Conditions
- Health Condition 1: O679- Intrapartum hemorrhage, unspecified
- Registration Number
- CTRI/2024/08/071777
- Lead Sponsor
- Jawaharlal Nehru Medical College And Datta Meghe Institute Of Higher Education And Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patients with age between 18-35 years Females.
2)Patients with ASA grade I, II.
3)Patient posted for cesarean section under spinal anesthesia.
4)Singleton pregnancy
5)Term gestation
6)Decision made for a cesarean section in labor
7)Who have given consent
Exclusion Criteria
1)Patients with ASA grade III, IV.
2)Women with known coagulopathy
3)Study drug hypersensitivity
4)Olygohydromnios or polyhydromnios
5)Cardiac disease (including dysarythmia)
6)Hypertension
7)Liver, renal or endocrine disease (except gestational diabetes)
8)Uterine fibroids or suspicion of placental pathology (accreta, previa or abruptio)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Carbetocin Is More Effective As Compared To Oxytocin In Reducing Intraoperative Bleeding During Cesarean SectionTimepoint: 3 Years
- Secondary Outcome Measures
Name Time Method The use of Carbetocin reduces the requirement for additional uterotonics and surgical maneuvers during cesarean sections in preventing uterine atony and intraoperative hemorrhage.Timepoint: 3 Years